Analysts’ Weekly Ratings Changes for CryoPort (CYRX)

Several brokerages have updated their recommendations and price targets on shares of CryoPort (NASDAQ: CYRX) in the last few weeks:

  • 8/9/2017 – CryoPort had its price target raised by analysts at Cowen and Company from $5.50 to $7.50. They now have an “outperform” rating on the stock.
  • 8/9/2017 – CryoPort had its price target raised by analysts at Janney Montgomery Scott from $8.00 to $10.00. They now have a “buy” rating on the stock.
  • 7/26/2017 – CryoPort had its price target raised by analysts at Needham & Company LLC from $6.00 to $8.50. They now have a “buy” rating on the stock.
  • 7/26/2017 – CryoPort was given a new $8.00 price target on by analysts at Janney Montgomery Scott. They now have a “buy” rating on the stock.
  • 7/13/2017 – CryoPort had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
  • 7/12/2017 – CryoPort is now covered by analysts at Janney Montgomery Scott. They set a “buy” rating and a $8.00 price target on the stock.
  • 6/26/2017 – CryoPort had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock, up previously from $4.50.
  • 6/16/2017 – CryoPort is now covered by analysts at Cowen and Company. They set an “outperform” rating and a $5.50 price target on the stock.

Shares of CryoPort, Inc. (NASDAQ CYRX) traded up 3.17% during trading on Wednesday, reaching $6.83. 298,458 shares of the company’s stock were exchanged. CryoPort, Inc. has a 52-week low of $1.80 and a 52-week high of $7.18. The company has a 50 day moving average price of $5.30 and a 200-day moving average price of $3.65. The company’s market capitalization is $163.75 million.

CryoPort (NASDAQ:CYRX) last posted its earnings results on Tuesday, August 8th. The company reported ($0.08) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.09) by $0.01. The business had revenue of $2.92 million for the quarter, compared to analysts’ expectations of $2.84 million. CryoPort had a negative net margin of 137.99% and a negative return on equity of 104.79%. On average, equities analysts forecast that CryoPort, Inc. will post ($0.72) earnings per share for the current year.

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Receive News & Ratings for CryoPort Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply